Akanda Corp.·Healthcare

Toronto, Ontario--(Newsfile Corp. - May 22, 2026) - Akanda Corp. (NASDAQ: AKAN) (the "Company" or "Akanda"), today announced that the Company is not in compliance with the periodic filing requirements for continued listing set forth in Nasdaq Listing Rule 5250(c)(1) as a result of its failure to file its Annual Report on Form 20-F for the fiscal year ended December 31, 2025 with the Securities and Exchange Commission by the required due date. The Company intends to file the Form 20-F as soon as practicable.

Toronto, Ontario--(Newsfile Corp. - May 22, 2026) - Akanda Corp. (NASDAQ: AKAN) (the "Company") today announced the cancellation of the special meeting of shareholders that was to be held at 10:00 am est on Monday, May 25, 2026, which was originally scheduled for March 31, 2026, adjourned to Monday, April 27, 2026 and subsequently further adjourned. A quorum for the transaction of business at the Meeting requires the presence, in person or by proxy, of at least two shareholders holding not less than 10% of the Company's outstanding shares entitled to vote.

Toronto, Ontario--(Newsfile Corp. - April 29, 2026) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company") today convened and subsequently adjourned its Special Meeting of Shareholders (the "Meeting") without transacting any business due to the absence of a quorum. The Meeting has been adjourned and will be reconvened in person in Toronto, Ontario on Monday, May 25, 2026 at 10:00 a.m.

Akanda Corp. (NASDAQ: AKAN - Get Free Report) saw a large drop in short interest in April. As of April 15th, there was short interest totaling 21,399 shares, a drop of 80.7% from the March 31st total of 110,750 shares. Based on an average daily volume of 29,824 shares, the short-interest ratio is currently 0.7 days.

Cerus (NASDAQ: CERS - Get Free Report) and Akanda (NASDAQ: AKAN - Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, risk, valuation, earnings, analyst recommendations, profitability and dividends. Profitability This table compares Cerus and Akanda's net margins,

Toronto, Ontario--(Newsfile Corp. - April 9, 2026) - Akanda Corp. (NASDAQ: AKAN) (the "Company" or "Akanda"), today announced that it expects to implement a 1-for-4.5 reverse stock split of the Company's common shares effective April 13, 2026. The reverse stock split was previously approved by the Company's shareholders on November 28, 2025 and Board of Directors on March 23, 2026 and will begin trading on an adjusted basis giving effect to the reverse stock split at the opening of market on April 13, 2026 under the existing ticker symbol "AKAN".
Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products in the United Kingdom, Lesotho, and internationally. It intends to supply cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.
Healthcare
Drug Manufacturers - Specialty & Generic
46
2022-03-15
1.73